Michael W Sims1, David J Margolis2, A Russell Localio2, Reynold A Panettieri3, Steven M Kawut4, Jason D Christie4. 1. Pulmonary, Allergy, and Critical Care Division, Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA; Airways Biology Initiative, Department of Medicine, and the Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA. Electronic address: michael.sims@uphs.upenn.edu. 2. Airways Biology Initiative, Department of Medicine, and the Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA. 3. Pulmonary, Allergy, and Critical Care Division, Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA. 4. Pulmonary, Allergy, and Critical Care Division, Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA; Airways Biology Initiative, Department of Medicine, and the Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA.
Abstract
BACKGROUND: Although pulmonary hypertension commonly complicates COPD, the functional consequences of increased pulmonary artery pressures in patients with this condition remain poorly defined. METHODS: We conducted a cross-sectional analysis of a cohort of 362 patients with severe COPD who were evaluated for lung transplantation. Patients with pulmonary hemodynamics measured by cardiac catheterization and available 6-min walk test results were included. The association of mean pulmonary artery pressure (mPAP) with pulmonary function, echocardiographic variables, and 6-min walk distance was assessed. RESULTS: The prevalence of pulmonary hypertension (mPAP, > 25 mm Hg; pulmonary artery occlusion pressure [PAOP], < 16 mm Hg) was 23% (95% confidence interval, 19 to 27%). In bivariate analysis, higher mPAP was associated with lower FVC and FEV(1), higher Pco(2) and lower Po(2) in arterial blood, and more right heart dysfunction. Multivariate analysis demonstrated that higher mPAP was associated with shorter distance walked in 6 min, even after adjustment for age, gender, race, height, weight, FEV(1), and PAOP (-11 m for every 5 mm Hg rise in mPAP; 95% confidence interval, -21 to -0.7; p = 0.04). CONCLUSIONS: Higher pulmonary artery pressures are associated with reduced exercise function in patients with severe COPD, even after controlling for demographics, anthropomorphics, severity of airflow obstruction, and PAOP. Whether treatments aimed at lowering pulmonary artery pressures may improve clinical outcomes in COPD, however, remains unknown.
BACKGROUND: Although pulmonary hypertension commonly complicates COPD, the functional consequences of increased pulmonary artery pressures in patients with this condition remain poorly defined. METHODS: We conducted a cross-sectional analysis of a cohort of 362 patients with severe COPD who were evaluated for lung transplantation. Patients with pulmonary hemodynamics measured by cardiac catheterization and available 6-min walk test results were included. The association of mean pulmonary artery pressure (mPAP) with pulmonary function, echocardiographic variables, and 6-min walk distance was assessed. RESULTS: The prevalence of pulmonary hypertension (mPAP, > 25 mm Hg; pulmonary artery occlusion pressure [PAOP], < 16 mm Hg) was 23% (95% confidence interval, 19 to 27%). In bivariate analysis, higher mPAP was associated with lower FVC and FEV(1), higher Pco(2) and lower Po(2) in arterial blood, and more right heart dysfunction. Multivariate analysis demonstrated that higher mPAP was associated with shorter distance walked in 6 min, even after adjustment for age, gender, race, height, weight, FEV(1), and PAOP (-11 m for every 5 mm Hg rise in mPAP; 95% confidence interval, -21 to -0.7; p = 0.04). CONCLUSIONS: Higher pulmonary artery pressures are associated with reduced exercise function in patients with severe COPD, even after controlling for demographics, anthropomorphics, severity of airflow obstruction, and PAOP. Whether treatments aimed at lowering pulmonary artery pressures may improve clinical outcomes in COPD, however, remains unknown.
Authors: Selim M Arcasoy; Jason D Christie; Victor A Ferrari; Martin St John Sutton; David A Zisman; Nancy P Blumenthal; Alberto Pochettino; Robert M Kotloff Journal: Am J Respir Crit Care Med Date: 2002-12-12 Impact factor: 21.405
Authors: R Kessler; M Faller; E Weitzenblum; A Chaouat; A Aykut; A Ducoloné; M Ehrhart; M Oswald-Mammosser Journal: Am J Respir Crit Care Med Date: 2001-07-15 Impact factor: 21.405
Authors: Steven M Scharf; Mobeen Iqbal; Cesar Keller; Gerald Criner; Shing Lee; Henry E Fessler Journal: Am J Respir Crit Care Med Date: 2002-08-01 Impact factor: 21.405
Authors: Jeremy P Wrobel; Catriona A McLean; Bruce R Thompson; Christopher R Stuart-Andrews; Eldho Paul; Gregory I Snell; Trevor J Williams Journal: Pulm Circ Date: 2013-12-11 Impact factor: 3.017
Authors: Eric J Gartman; Michael Blundin; James R Klinger; Joe Yammine; Mary B Roberts; F Dennis McCool Journal: Lung Date: 2011-11-18 Impact factor: 2.584